Long-Term Risk of Subsequent Neoplasms in 5-Year Survivors of Childhood Neuroblastoma: A Dutch Childhood Cancer Survivor Study-LATER 3 Study
Our results demonstrate that neuroblastoma survivors have an elevated risk of developing SMNs and a high risk of SNMNs. <sup>131I</sup>MIBG may be a treatment-related risk factor for the development of SMN and SNMN, which needs further validation. Our results emphasize the need for awareness of subsequent neoplasms and the importance of follow-up care.
Authors
- Jacqueline J. Loonen (ORCID: https://orcid.org/0000-0002-9963-8367)
- Andrica de Vries (ORCID: https://orcid.org/0000-0003-0964-0007)
- Helena J. H. van der Pal (ORCID: https://orcid.org/0000-0003-2253-2115)
- Max M. van Noesel (ORCID: https://orcid.org/0000-0003-0503-5838)
- Aimée S.R. Westerveld (ORCID: https://orcid.org/0000-0003-3215-8964)
- Jop C. Teepen (ORCID: https://orcid.org/0000-0002-2647-2677)
- Marloes Louwerens (ORCID: https://orcid.org/0000-0002-6748-3540)
- Hanneke M. van Santen (ORCID: https://orcid.org/0000-0002-6773-6931)
- Ronald R. de Krijger (ORCID: https://orcid.org/0000-0001-6871-1296)
- Leontien C.M. Kremer (ORCID: https://orcid.org/0000-0001-7422-3248)
- Cécile M. Ronckers (ORCID: https://orcid.org/0000-0003-3524-4657)
- Margriet van der Heiden‐van der Loo (ORCID: https://orcid.org/0000-0001-5767-854X)
- Geert O. Janssens (ORCID: https://orcid.org/0000-0002-0331-713X)
- Maria M.W. Koopman
- Godelieve A.M. Tytgat (ORCID: https://orcid.org/0000-0003-2356-5197)
Institutions
- Radboud University Nijmegen (NL)
- Johannes Gutenberg University Mainz (DE)
- Leiden University Medical Center (NL)
- Erasmus MC (NL)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Emma Kinderziekenhuis (NL)
- Princess Máxima Center (NL)
- Amsterdam University Medical Centers (NL)
- Wilhelmina Children's Hospital (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1200/jco.23.01430
- Citations
- 2
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.74